Denali Therapeutics Inc. DNLI Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Based on trailing twelve months.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s return on invested capital?
- Denali Therapeutics Inc. (DNLI) reported return on invested capital of -64.8% in Q1 2026.
- How has Denali Therapeutics Inc.'s return on invested capital changed year-over-year?
- Denali Therapeutics Inc.'s return on invested capital decreased by 60.8% year-over-year, from -40.3% to -64.8%.
- What is the long-term trend for Denali Therapeutics Inc.'s return on invested capital?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s return on invested capital has grown at a 37.8% compound annual growth rate (CAGR), from 11.4% to -56.8%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.